Objective: To evaluate the seasonal change in serum 25-hydroxyvitamin D (25-OHD) level in healthy infants and to relate it to common childhood morbidities.
Methods: 72 healthy breastfed infants residing in Delhi were enrolled at the end of summer and followed till the end of winter [mean (SD) duration 200 (10) d]. Serum 25-OHD was estimated at baseline and follow-up. Infants were monitored for common childhood diseases.
Results: Mean (SD) serum 25-OHD level was lower at the end of winter (20.7 (8.02) ng/mL) than summer (22.9 (8.70) ng/mL) [mean difference (95% CI) -2.14 ng/mL (-3.36, -1.06), P<0.001). The seasonal distribution of children according to vitamin D status in summer and winter - Deficient (15.3%, 12.5%), Insufficient (19.4%, 30.6%) and Sufficient (65.3%, 56.9%), respectively was comparable P=0.17). The morbidity profile remained unaffected by change in vitamin D status from summer to winter.
Conclusions: Seasonal changes in vitamin D levels do not have significant clinical effect or effect on overall vitamin D status in apparently healthy infants from North India. This may have implications for results of population surveys for vitamin D status, irrespective of the season when they are conducted.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Maternal-Newborn ABO Blood Group Congruence Among Consecutive Births and Risk of Serious Neonatal Infection: Retrospective Cohort Study.
Pediatr Infect Dis J
January 2025
From the ICES, Toronto, Ontario, Canada.
Background: Differing ABO blood groups between a mother and her fetus may confer a lower risk of serious neonatal infection. How sensitization in the first pregnancy influences this phenomenon in a subsequent pregnancy is unclear. Accordingly, this study determined whether maternal-newborn ABO blood group incongruence in a first pregnancy further modifies the risk of serious infection in a subsequent pregnancy marked by ABO incongruency.
View Article and Find Full Text PDFNew Zealand Early Learning Service Menus Do Not Meet Health New Zealand Guidelines for Providing Healthy Menus and Reducing Food-Related Choking in Children.
Health Promot J Austr
January 2025
School of Sport, Exercise and Nutrition, Massey University, Auckland, New Zealand.
Objective: To assess alignment of food and drinks served to New Zealand (NZ) children in early learning services (ELS) with the Health NZ (formerly known as Ministry of Health) Healthy Food and Drink (HFD) and Reducing Food Related Choking (choking) guidance.
Methods: Menus (271) collected remotely from 148 ELS from November 2020-March 2021 were analysed for their nutritional quality based on a 'traffic light' classification of 'green' (most nutritious), 'amber' (moderately nutritious) and 'red' (least nutritious) based on the guidance.
Results: Overall, 2.
Safety, Tolerability, and Immunogenicity of the Invaplex Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial.
Vaccines (Basel)
January 2025
Leiden University Center for Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Background: Shigella infections remain endemic in places with poor sanitation and are a leading cause of diarrheal mortality globally, as well as a major contributor to gut enteropathy and stunting. There are currently no licensed vaccines for shigellosis but it has been estimated that an effective vaccine could avert 590,000 deaths over a 20-year period. A challenge to effective Shigella vaccine development has been the low immunogenicity and protective efficacy of candidate Shigella vaccines in infants and young children.
View Article and Find Full Text PDFEvaluating Metabolic Profiling of Human Milk Using Biocrates MxP QUANT 500 Assay.
Metabolites
January 2025
Department of Nutrition, University of California, Davis, CA 95616, USA.
Metabolic profiling of human milk (HM) is indispensable for elucidating mother-milk-infant relationships. We evaluated the Biocrates MxP Quant 500 assay for HM-targeted metabolomics (106 small molecules, 524 lipids) and analyzed in a feasibility test HM from apparently healthy Brazilian mothers (A: 2-8, B: 28-50, C: 88-119 days postpartum, n = 25). Of the 630 possible signatures detectable with this assay, 506 were above the limits of detection in an HM-pool (10 µL) used for assay evaluation, 12 of them above the upper limit of quantitation.
View Article and Find Full Text PDFFlow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and Thrombosis.
Cells
January 2025
Research Department, Sidra Medicine, Doha P.O. Box 26999, Qatar.
Hemophilia A (HA) is associated with FVIII coagulation insufficiency or inactivity leading to excessive bleeding. Elevated FVIII, on the contrary, is associated with thrombophilia, thrombosis, myocardial infarctions, and stroke. Active FVIII (aFVIII) uses its C2 domain to bind to blood cells' membranes, consequently carrying out its coagulative function.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!